Open AccessPredictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
Author(s) -
Ruth Stuckey,
Juan Francisco LópezRodríguez,
Santiago Sánchez-Sosa,
Adrián Segura-Díaz,
Nuria Sánchez-Farías,
Cristina Bilbao-Sieyro,
María Teresa GómezCasares
Publication year - 2020
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v11.i12.996
Subject(s) - discontinuation , medicine , myeloid leukemia , tyrosine kinase , tyrosine kinase inhibitor , oncology , clinical trial , intensive care medicine , cancer , receptor